Since 2003 Trevor has founded and managed companies dedicated to developing and commercializing treatments for orphan-status diseases. He sold his...
Simultaneous multi-pathway inhibition
Low toxicity permits high payload > 600mg/m2
Synergy with multiple mAbs
Overcoming late-stage, solid,
drug-resistant tumors with novel
multi-functional small molecules
that simultaneously inhibit multiple targets, to safely overcome
the urgent and unsolved problem of multi-drug resistance
without myelosuppression or GI effects while also stimulating
target antigen expression to enhance immunotherapy
We develop cancer drugs
NEV-801 is a combination small molecule consisting of structurally redesigned derivatives of irinotecan and etoposide with a stabilizing linker
Our World Class Team
We provide world-class R&D and clinical capabilities while allowing management to focus on growth and development
If you’d like to discuss or have questions, please fill in the contact form or call us to speak to a member of our team
Neovia has global chemical-composition & use patents
USA, PCT, & China composition and use patents through 2038
Companies and Institutions Behind Our Success
ANU Pharmaceutical Company is an incubator company for the early-stage development of novel oncology compounds.
PUMC Pharmaceutical is a specialty pharmaceutical company.Since 1995, we have been working closely with the Peking Union Medical College (PUMC), the Chinese Ministry of Health and our international partners to meet the unmet medical needs of patients in China and around the world.
Prevail InfoWorks is a system integration and analytics software company with a unique combination of clinical expertise and engineering prowess. Providing best in Class Modular Technology for Improved Timelines and early observations in clinical trials. Prevail is managing Neovia’s first-in-human trial for NEV-801
The University of Iowa Pharmaceuticals has been manufacturing and testing pharmaceutical products in compliance with cGMPs for over 40 years. UIP provides contract pharmaceutical formulation development, clinical supply, and commercial manufacturing and analytical testing services for Neovia
Since 1973, Raymond has founded companies involved in health care, high technology, investment banking, real estate, and manufacturing across the...
Dr Yang is Senior Scientist and Scientific Director of an integrated citywide graduate medical education program in radiation oncology at...
Previously, Gerald worked in New York, London, San Francisco and Washington D.C. in various finance and strategy positions, including as...